Sunzen Biotech Berhad (KLSE: SUNZEN)

Market Cap	228.93M
Revenue (ttm)	95.13M
Net Income (ttm)	6.11M
Shares Out	715.42M
EPS (ttm)	0.01
PE Ratio	37.72
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	90,100
Open	0.320
Previous Close	0.320
Day's Range	0.320 - 0.320
52-Week Range	0.190 - 0.400
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 24, 2024

About Sunzen Biotech Berhad

Sunzen Biotech Berhad engages in the biotechnology research and development, manufacturing, and marketing of animal feed supplement products in Malaysia, China, Singapore, and internationally. The company provides veterinary machines, pharmaceutical, chemical products, animal health products and equipment, laboratory services, and beauty and cosmetic products. It also manufactures and sells traditional Chinese medicine, herbal health foods, beverages, and other products; trades in crude palm oil and derivative products; and manufactures, import...

• Industry: Pharmaceutical Preparations
• Founded: 1998
• Country: Malaysia
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: SUNZEN

Financial Performance

In 2024, Sunzen Biotech Berhad's revenue was 95.13 million, a decrease of -3.05% compared to the previous year's 98.13 million. Earnings were 6.11 million, a decrease of -10.05%.